TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 1 | 3 | -5 | 0 | 0 | 0 | -0 |
P | %wins | 100 | 100 | 0 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/18/20 17:30 | 6/16/20 | AGEN | Agenus Inc | DE | Health | Biolab | Commercial Physical & Biologi | Incyte Corp | DE | T | S.m | -783 | 3.66 | 0 | -214 | -1 | 16,973 | D | |||||||||||||||
6/15/20 20:47 | 6/11/20 | AGEN | Agenus Inc | DE | Health | Biolab | Commercial Physical & Biologi | Incyte Corp | DE | T | S.m | -2,098 | 3.64 | 0 | -577 | -3 | 17,187 | D | |||||||||||||||
2/14/17 17:26 | 2/14/17 | AGEN | Agenus Inc | DE | Health | BioPrd | Biological Products, (No Diag | Incyte Corp | DE | T | P | 60,000 | 6.00 | 3 | 10,000 | 129 | 17,764 | D | -18 | 46 | -34 | -20 | 0 | 9 | 5 | 4 | 1 | 3 | -5 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |